- Sections
- C - Chimie; métallurgie
- C07H - Sucres; leurs dérivés; nucléosides; nucléotides; acides nucléiques
- C07H 15/207 - Cycles cyclohexane non substitués par des atomes d'azote, p.ex. kasugamycines
Détention brevets de la classe C07H 15/207
Brevets de cette classe: 144
Historique des publications depuis 10 ans
8
|
17
|
9
|
14
|
9
|
14
|
11
|
14
|
7
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
GlycoMimetics, Inc. | 133 |
40 |
University of Kansas | 860 |
6 |
Galecto Biotech AB | 84 |
4 |
Reata Pharmaceuticals, Inc. | 121 |
4 |
Vertex Pharmaceuticals Incorporated | 1576 |
3 |
Asahi Kasei Chemicals Corporation | 721 |
3 |
Cargill, Incorporated | 2896 |
3 |
Washington University | 1538 |
3 |
Genentech, Inc. | 3867 |
2 |
Boehringer Ingelheim Vetmedica GmbH | 1289 |
2 |
Brown University | 628 |
2 |
Grifols Shared Services North America, Inc. | 12 |
2 |
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 164 |
2 |
Trustees of Tufts College | 818 |
2 |
Universitat Basel | 283 |
2 |
Ventana Medical Systems, Inc. | 1003 |
2 |
The Board of Regents of the University of Texas System | 2132 |
2 |
IntoCell Inc. | 25 |
2 |
Huzhou Center of Bio-synthetic Innovation, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 2 |
2 |
Cartilago S.r.l. | 4 |
2 |
Autres propriétaires | 54 |